Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2007
05/31/2007WO2006039215A3 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
05/31/2007US20070123705 Alkylation; serotonin receptor antagonists; depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety, sexual dysfunction, bulimia, obesity, addictive disorder
05/31/2007US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
05/31/2007US20070123560 Dehalogeno-compounds
05/31/2007US20070123553 Aryl imidazoles and their use as anti-cancer agents
05/31/2007US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis
05/31/2007US20070123548 Pth agonists
05/31/2007US20070123532 Piperazine derivatives
05/31/2007US20070123531 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
05/31/2007US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
05/31/2007US20070123523 Inhibitors of cathepsin s
05/31/2007US20070123509 Carboxamide derivatives
05/31/2007US20070122444 Medical devices employing triazine compounds and compositions thereof
05/31/2007US20070119000 Cationic naphthalene dyes and colorants for keratin fibers, particularly human hair; 4-{(E)-[(1,3-diketo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)imino]methyl}-1-(2-hydroxyethyl)pyridinium bromide, for example
05/31/2007CA2824307A1 F, g, h, i and k crystal forms of imatinib mesylate
05/31/2007CA2824301A1 F, g, h, i and k crystal forms of imatinib mesylate
05/31/2007CA2630655A1 Isoquinoline et benzo[h]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of histamine h3 receptor
05/31/2007CA2630234A1 Thrombopoietin activity modulating compounds and methods
05/31/2007CA2629554A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
05/31/2007CA2629527A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
05/31/2007CA2628540A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor
05/31/2007CA2628527A1 Modulators of the h3 receptor useful for the treatment of disorders related thereto
05/31/2007CA2628330A1 F,g,h,i and k crystal forms of imatinib mesylate
05/30/2007EP1790647A1 Method and apparatus for producing oxidized compound
05/30/2007EP1790646A1 Isoquinoline und benzo[h]isoquinoline derivatives, their preparation and their therapeutical application as antagonists of histamine H3 receptor .
05/30/2007EP1790641A1 Triazole derivative or salt thereof
05/30/2007EP1790639A1 Compound containing basic group and use thereof
05/30/2007EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
05/30/2007EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
05/30/2007EP1790636A1 Piperidine derivatives and use thereof
05/30/2007EP1789633A2 Benzamide compounds
05/30/2007EP1789419A1 Gyrase inhibitors and uses thereof
05/30/2007EP1789413A1 Vanilloid receptor ligands and their use in treatments
05/30/2007EP1789411A1 Novel anthranilamides useful for controlling invertebrate pests
05/30/2007EP1789410A1 Methylene dipiperidine derivatives
05/30/2007EP1789409A2 Sulfonamides and uses thereof
05/30/2007EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors
05/30/2007EP1789397A2 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
05/30/2007EP1789395A1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
05/30/2007EP1789392A2 Preparation of pyridonecarboxylic acid antibacterials
05/30/2007EP1789391A1 Bivalent linkers and conjugates thereof
05/30/2007EP1789390A2 Pyridyl inhibitors of hedgehog signalling
05/30/2007EP1789389A1 Piperidine compound and process for preparing the same
05/30/2007EP1789386A1 Substituted indole compounds, their preparation and use in medicaments
05/30/2007EP1789049A2 Cyclic amide and ester pyrazinoylguanidine sodium channel blockers
05/30/2007EP1789041A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
05/30/2007EP1556372B1 Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists
05/30/2007EP1539743B1 Pyrazole derivatives as gnrh inhibitors
05/30/2007EP1487818B1 Alkylammonium salts of omeprazole and esomeprazole
05/30/2007EP1476441B1 A method of eliminating sulfone analog in the synthesis of pyridine-benzimidazole sulfoxides
05/30/2007EP1411053B1 Method for obtaining derivatives of (pyridil substituted)methyl|thio|benzimidazol
05/30/2007EP1392291B1 Tripeptidyl peptidase inhibitors
05/30/2007EP1373220B1 Benzimidazoles that are useful in treating sexual dysfunction
05/30/2007EP1318814B1 Triazole compounds useful as protein kinase inhibitors
05/30/2007EP1285655B1 Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine
05/30/2007EP1180103B1 Renin inhibitors
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/30/2007CN1972942A Imidazole variants as modulators of gaba receptor for the treatment of gi disorders
05/30/2007CN1972932A Compounds and methods for treating dyslipidemia
05/30/2007CN1972930A Novel pyridazinone derivatives as inhibitors of CDK2
05/30/2007CN1972929A Heterocyclic CGRP antagonists for the treatment of migraine
05/30/2007CN1972928A New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
05/30/2007CN1972927A Compounds and methods for treating dyslipidemia
05/30/2007CN1972926A Indole derivatives as histamine receptor antagonists
05/30/2007CN1972925A Substituted bisarylurea derivatives
05/30/2007CN1972924A Novel compounds
05/30/2007CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5
05/30/2007CN1972922A 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi
05/30/2007CN1972921A 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
05/30/2007CN1972919A Method for producing 4-(benzimidazolylmethylamino)-benzamidines
05/30/2007CN1972918A 嘧啶衍生物 Pyrimidine derivatives
05/30/2007CN1972911A 2-(1h-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence
05/30/2007CN1972688A 4-phenylamino-quinazolin-6-yl-amides
05/30/2007CN1970553A 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method
05/30/2007CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application
05/30/2007CN1318918C Charge transfer compound, organic light sensor containing said compound for electronic photography and imaging device and method for electronic photography
05/30/2007CN1318416C Indazole amide compounds as 5-serotoninergic agents
05/30/2007CN1318415C Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro- 2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine-carboxylate-racemate
05/30/2007CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same
05/30/2007CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
05/30/2007CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
05/29/2007US7223879 Reactibng transition metal with boron compound and sulfonate compound
05/29/2007US7223862 Herbicides; reacting diazoester with the corresponding tetrahydropyridine compound
05/29/2007US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/29/2007US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders
05/29/2007US7223785 Viral polymerase inhibitors
05/29/2007US7223783 Indolinone derivatives
05/29/2007US7223782 Pyrazole-amides and -sulfonamides
05/29/2007US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets
05/29/2007US7223778 5-substituted-2-arylpyridines
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223776 Compounds with anti-bacterial activity
05/29/2007US7223768 Fused ring heterocycles as potassium channel modulators
05/29/2007US7223767 Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists
05/29/2007US7223766 Bi-cyclic pyrimidine inhibitors of TGFβ
05/29/2007US7223764 Antilipemic agents; anticholesterol agents
05/29/2007US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity
05/29/2007US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example
05/29/2007US7223760 Substituted triazole compounds